Q1 2020 13F Holders as of 3/31/2020
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
159M
-
Number of holders
-
339
-
Total 13F shares, excl. options
-
117M
-
Shares change
-
-2.68M
-
Total reported value, excl. options
-
$5.55B
-
Value change
-
-$142M
-
Put/Call ratio
-
1.27
-
Number of buys
-
132
-
Number of sells
-
-188
-
Price
-
$47.28
Significant Holders of IONIS PHARMACEUTICALS INC - COMMON STOCK (IONS) as of Q1 2020
436 filings reported holding IONS - IONIS PHARMACEUTICALS INC - COMMON STOCK as of Q1 2020.
IONIS PHARMACEUTICALS INC - COMMON STOCK (IONS) has 339 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 117M shares
of 159M outstanding shares and own 74.1% of the company stock.
Largest 10 shareholders include FMR LLC (21M shares), VANGUARD GROUP INC (12.1M shares), BAILLIE GIFFORD & CO (8.75M shares), Bellevue Group AG (8.38M shares), BlackRock Inc. (8.17M shares), Clearbridge Investments, LLC (8.03M shares), WELLINGTON MANAGEMENT GROUP LLP (3.99M shares), STATE STREET CORP (3.89M shares), PRICE T ROWE ASSOCIATES INC /MD/ (3.76M shares), and Invesco Ltd. (2.34M shares).
This table shows the top 339 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.